D.A. Davidson & CO. Decreases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
D.A. Davidson & CO. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 753 shares of the biopharmaceutical company’s stock after selling 68 shares during the quarter. D.A. Davidson & CO.’s […]
D.A. Davidson & CO. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 753 shares of the biopharmaceutical company’s stock after selling 68 shares during the quarter. D.A. Davidson & CO.’s […]
